Transcriptional antagonism by CDK8 inhibition improves therapeutic efficacy of MEK inhibitors

被引：0
|
作者：
Malone, Clare F. [1 ]
Kim, Minjee [1 ]
Alexe, Gabriela [1 ]
Forman, Alexandra B. [1 ]
Robichaud, Amanda [1 ]
Conway, Amy Saur [1 ]
Goodale, Amy [2 ]
Hatcher, John M. [1 ]
Gray, Nathanael S. [3 ]
Piccioni, Federica [2 ]
Stegmaier, Kimberly [1 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA USA
[2] Broad Inst, Cambridge, MA USA
[3] Stanford Univ, Stanford, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2010
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Transcriptional Antagonism by CDK8 Inhibition Improves Therapeutic Efficacy of MEK Inhibitors
    Malone, Clare F.
    Kim, Minjee
    Alexe, Gabriela
    Engel, Kathleen
    Forman, Alexandra B.
    Robichaud, Amanda
    Conway, Amy Saur
    Goodale, Amy
    Meyer, Ashleigh
    Khalid, Delan
    Thayakumar, Allen
    Hatcher, John M.
    Gray, Nathanael S.
    Piccioni, Federica
    Stegmaier, Kimberly
    CANCER RESEARCH, 2023, 83 (02) : 285 - 300
  • [2] CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors
    Xi, Meiyang
    Chen, Tingkai
    Wu, Chunlei
    Gao, Xiaozhong
    Wu, Yonghua
    Luo, Xiang
    Du, Kui
    Yu, Lemao
    Cai, Tao
    Shen, Runpu
    Sun, Haopeng
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 164 : 77 - 91
  • [3] Preventing adaptive therapeutic resistance to CDK4/6 inhibition with CDK8/19 inhibitors
    Mack, Zachary
    Yastrebova, Margarita
    Khamidullina, Alvina
    Sharko, Amanda
    Ding, Xiaokai
    Bowe, Stephan
    Sashi, Nikitha
    Safa, Samantha
    Digsby, Kaitlyn
    Eckstrom, Amanda
    Sikirzhitski, Vitali
    Lim, Chang-Uk
    Tatarskiy, Victor
    Roninson, Igor
    Broude, Eugenia
    CANCER RESEARCH, 2022, 82 (04)
  • [4] CDK8/CDK19 inhibition as therapeutic target of metastatic prostate cancer
    Offermann, A.
    Becker, F.
    Kluemper, N.
    Vogel, W.
    Braegelmann, J.
    Perner, S.
    VIRCHOWS ARCHIV, 2017, 471 : S269 - S269
  • [5] CDK8 Inhibitors Induce Transcriptional Reprogramming of AML Cells Associated with Differentiation
    Mazan, Milena
    Chapellier, Marion
    Jaras, Marcus
    Mikula, Michal
    Majewska, Eliza
    Wiklik, Katarzyna
    Combik, Michal
    Golas, Aniela
    Masiejczyk, Magdalena
    Fiedor, Elzbieta
    Malusa, Federico
    Juszczynski, Przemyslaw
    Cybulska, Magdalena
    Mikulski, Maciej
    Ostrowski, Jerzy
    Chrom, Pawel
    Brzozka, Krzysztof
    Rzymski, Tomasz
    BLOOD, 2019, 134
  • [6] CDK8 inhibition improves the efficacy of ER- and HER2-targeted drugs in breast cancer
    McDermott, M. S.
    Chumanevich, A.
    Liang, J.
    Chen, M.
    Altilia, S.
    Hennes, C.
    Roninson, I. B.
    Broude, E. V.
    CANCER RESEARCH, 2017, 77
  • [7] Taking Aim at Glycolysis with CDK8 Inhibitors
    Fisher, Robert P.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2018, 29 (05): : 281 - 282
  • [8] In Search of Novel CDK8 Inhibitors by Virtual Screening
    Kumarasiri, Malika
    Teo, Theodosia
    Yu, Mingfeng
    Philip, Stephen
    Basnet, Sunita K. C.
    Albrecht, Hugo
    Sykes, Matthew J.
    Wang, Peng
    Wang, Shudong
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2017, 57 (03) : 413 - 416
  • [9] Biomarker Discovery for Cancer Sensitivity to CDK8 Inhibitors
    Lu, Zhixin
    Spear, Jensen E.
    Russu, Wade A.
    FASEB JOURNAL, 2018, 32 (01):
  • [10] CDK8/19 inhibitors: 3-benzylindazoles
    Schiemann, Kai
    Mallinger, Aurelie
    Wienke, Dirk
    Esdar, Christina
    Poeschke, Oliver
    Busch, Michael
    Rohdich, Felix
    Eccles, Suzanne
    Schneider, Richard
    Raynaud, Florence
    Czodrowski, Paul
    Musil, Djordje
    Schwarz, Daniel
    Urbahns, Klaus
    Blagg, Julian
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
12345